Scientific Advisory Board

The members of the Celator Scientific Advisory Board are recognized world leaders in cancer research, clinical oncology and drug development.

Alan Sartorelli, Ph.D. (Chairman), Alfred Gilman Professor of Pharmacology, Yale University

Emil Frei III, M.D. (Emeritus Member), Physician-in-Chief Emeritus, Dana-Farber Cancer Institute

Fred Appelbaum, M.D., Ph.D., Director of the Clinical Research Division, Fred Hutchinson Cancer Research Center; Head of the Division of Medical Oncology, University of Washington

Joseph Bertino, M.D., Interim Director, The Cancer Institute of New Jersey

Stephen Carter, M.D., Former Senior Vice President, Worldwide Clinical R&D, Bristol-Myers Squibb

Edward Chu, M.D., Deputy Director and Chief of Medical Oncology, Yale Cancer Center; Professor of Medicine and Pharmacology, Yale University School of Medicine

Ross C. Donehower , M.D., Director of the Division of Medical Oncology at The Johns Hopkins Oncology Center and Professor of Oncology at The Johns Hopkins University School of Medicine

John Lazo, Ph.D., Professor and Chair, Department of Pharmacology, University of Pittsburgh School of Medicine and C-Director of the Molecular Therapeutics/Drug Discovery Program at the University of Pittsburgh Cancer Institute